MedPath

IMPACT Biotech Ltd

🇮🇱Israel
Ownership
Private
Established
2003-02-13
Employees
-
Market Cap
-
Website
https://impact.pub/

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma

Phase 1
Recruiting
Conditions
Locally Advanced Unresectable Pancreatic Adenocarcinoma
First Posted Date
2023-06-26
Last Posted Date
2025-02-11
Lead Sponsor
Impact Biotech Ltd
Target Recruit Count
30
Registration Number
NCT05919238
Locations
🇺🇸

City of Hope, Duarte, California, United States

🇺🇸

University of California Irvine, Irvine, California, United States

Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer

Phase 1
Recruiting
Conditions
Peripheral Lung Tumor
First Posted Date
2023-06-26
Last Posted Date
2025-02-11
Lead Sponsor
Impact Biotech Ltd
Target Recruit Count
36
Registration Number
NCT05918783
Locations
🇺🇸

Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.